October 30, 2020


Syneos Health colleagues Nick Kenny, PhD, and Stephen Keith, MD, invited ex-FDA Commissioner Peggy Hamburg, MD, for a discussion on the lack of patient diversity in clinical trials. Watch as they discuss the current state of affairs, progress made, and next steps.


  • Peggy Hamburg, MD, Former FDA Commissioner (2009-2015)
  • Nick Kenny, PhD, Chief Scientific Officer, Syneos Health
  • Stephen Keith, MD, VP, Medical & Scientific Strategy, Syneos Health